The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes

Jill Crandall, David Schade, Yong Ma, Wilfred Y. Fujimoto, Elizabeth Barrett-Connor, Sarah Fowler, Samuel Dagogo-Jack, Reubin Andres

Research output: Contribution to journalArticle

170 Citations (Scopus)

Abstract

Background. The incidence of type 2 diabetes increases with age. It is unknown whether interventions to prevent diabetes are as effective in elderly persons as in younger adults. Methods. The Diabetes Prevention Program (DPP) demonstrated that an intensive lifestyle intervention (ILS) or metformin could prevent or delay diabetes. A predefined secondary outcome of DPP was to determine if treatment effects varied by age. Results. At baseline, participants aged 60-85 years were leaner and had the best insulin sensitivity and lowest insulin secretion compared to younger age groups. Diabetes incidence rates did not differ by age in the placebo group, but ILS was more effective with increasing age (6.3, 4.9, and 3.3 cases per 100 person-years, in the 25-44, 45-59, and 60-85 year age groups, respectively; ptrend = .007). Participants aged 60-85 years had the most weight loss and metabolic equivalent (MET)-hours of physical activity. The metformin group showed a trend toward higher diabetes incidence among older participants (6.7, 7.7, and 9.3 cases per 100 person-years in the 25-44, 45-59, and 60-85 year age groups, respectively, ptrend = .07); and diabetes risk increased with age (hazard ratio [age 60-85 vs 25-44] 1.63, p = .02), after adjusting for the greater weight loss in the 60-85 year age group. Conclusions. Lifestyle modification was exceptionally effective in preventing diabetes in older individuals; this finding was largely explained by greater weight loss and physical activity. The limited effectiveness of metformin in older persons may reflect age-related differences in insulin action and secretion. A lifestyle modification program can be recommended for older individuals at high risk for type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)1075-1081
Number of pages7
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume61
Issue number10
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Metformin
Life Style
Age Groups
Weight Loss
Type 2 Diabetes Mellitus
Incidence
Metabolic Equivalent
Exercise
Insulin
Insulin Resistance
Young Adult
Placebos
Therapeutics

All Science Journal Classification (ASJC) codes

  • Aging
  • Geriatrics and Gerontology

Cite this

The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. / Crandall, Jill; Schade, David; Ma, Yong; Fujimoto, Wilfred Y.; Barrett-Connor, Elizabeth; Fowler, Sarah; Dagogo-Jack, Samuel; Andres, Reubin.

In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 61, No. 10, 01.01.2006, p. 1075-1081.

Research output: Contribution to journalArticle

Crandall, Jill ; Schade, David ; Ma, Yong ; Fujimoto, Wilfred Y. ; Barrett-Connor, Elizabeth ; Fowler, Sarah ; Dagogo-Jack, Samuel ; Andres, Reubin. / The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2006 ; Vol. 61, No. 10. pp. 1075-1081.
@article{4aa455d3330b41b6a09099d5e3bd0c1a,
title = "The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes",
abstract = "Background. The incidence of type 2 diabetes increases with age. It is unknown whether interventions to prevent diabetes are as effective in elderly persons as in younger adults. Methods. The Diabetes Prevention Program (DPP) demonstrated that an intensive lifestyle intervention (ILS) or metformin could prevent or delay diabetes. A predefined secondary outcome of DPP was to determine if treatment effects varied by age. Results. At baseline, participants aged 60-85 years were leaner and had the best insulin sensitivity and lowest insulin secretion compared to younger age groups. Diabetes incidence rates did not differ by age in the placebo group, but ILS was more effective with increasing age (6.3, 4.9, and 3.3 cases per 100 person-years, in the 25-44, 45-59, and 60-85 year age groups, respectively; ptrend = .007). Participants aged 60-85 years had the most weight loss and metabolic equivalent (MET)-hours of physical activity. The metformin group showed a trend toward higher diabetes incidence among older participants (6.7, 7.7, and 9.3 cases per 100 person-years in the 25-44, 45-59, and 60-85 year age groups, respectively, ptrend = .07); and diabetes risk increased with age (hazard ratio [age 60-85 vs 25-44] 1.63, p = .02), after adjusting for the greater weight loss in the 60-85 year age group. Conclusions. Lifestyle modification was exceptionally effective in preventing diabetes in older individuals; this finding was largely explained by greater weight loss and physical activity. The limited effectiveness of metformin in older persons may reflect age-related differences in insulin action and secretion. A lifestyle modification program can be recommended for older individuals at high risk for type 2 diabetes.",
author = "Jill Crandall and David Schade and Yong Ma and Fujimoto, {Wilfred Y.} and Elizabeth Barrett-Connor and Sarah Fowler and Samuel Dagogo-Jack and Reubin Andres",
year = "2006",
month = "1",
day = "1",
doi = "10.1093/gerona/61.10.1075",
language = "English (US)",
volume = "61",
pages = "1075--1081",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes

AU - Crandall, Jill

AU - Schade, David

AU - Ma, Yong

AU - Fujimoto, Wilfred Y.

AU - Barrett-Connor, Elizabeth

AU - Fowler, Sarah

AU - Dagogo-Jack, Samuel

AU - Andres, Reubin

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Background. The incidence of type 2 diabetes increases with age. It is unknown whether interventions to prevent diabetes are as effective in elderly persons as in younger adults. Methods. The Diabetes Prevention Program (DPP) demonstrated that an intensive lifestyle intervention (ILS) or metformin could prevent or delay diabetes. A predefined secondary outcome of DPP was to determine if treatment effects varied by age. Results. At baseline, participants aged 60-85 years were leaner and had the best insulin sensitivity and lowest insulin secretion compared to younger age groups. Diabetes incidence rates did not differ by age in the placebo group, but ILS was more effective with increasing age (6.3, 4.9, and 3.3 cases per 100 person-years, in the 25-44, 45-59, and 60-85 year age groups, respectively; ptrend = .007). Participants aged 60-85 years had the most weight loss and metabolic equivalent (MET)-hours of physical activity. The metformin group showed a trend toward higher diabetes incidence among older participants (6.7, 7.7, and 9.3 cases per 100 person-years in the 25-44, 45-59, and 60-85 year age groups, respectively, ptrend = .07); and diabetes risk increased with age (hazard ratio [age 60-85 vs 25-44] 1.63, p = .02), after adjusting for the greater weight loss in the 60-85 year age group. Conclusions. Lifestyle modification was exceptionally effective in preventing diabetes in older individuals; this finding was largely explained by greater weight loss and physical activity. The limited effectiveness of metformin in older persons may reflect age-related differences in insulin action and secretion. A lifestyle modification program can be recommended for older individuals at high risk for type 2 diabetes.

AB - Background. The incidence of type 2 diabetes increases with age. It is unknown whether interventions to prevent diabetes are as effective in elderly persons as in younger adults. Methods. The Diabetes Prevention Program (DPP) demonstrated that an intensive lifestyle intervention (ILS) or metformin could prevent or delay diabetes. A predefined secondary outcome of DPP was to determine if treatment effects varied by age. Results. At baseline, participants aged 60-85 years were leaner and had the best insulin sensitivity and lowest insulin secretion compared to younger age groups. Diabetes incidence rates did not differ by age in the placebo group, but ILS was more effective with increasing age (6.3, 4.9, and 3.3 cases per 100 person-years, in the 25-44, 45-59, and 60-85 year age groups, respectively; ptrend = .007). Participants aged 60-85 years had the most weight loss and metabolic equivalent (MET)-hours of physical activity. The metformin group showed a trend toward higher diabetes incidence among older participants (6.7, 7.7, and 9.3 cases per 100 person-years in the 25-44, 45-59, and 60-85 year age groups, respectively, ptrend = .07); and diabetes risk increased with age (hazard ratio [age 60-85 vs 25-44] 1.63, p = .02), after adjusting for the greater weight loss in the 60-85 year age group. Conclusions. Lifestyle modification was exceptionally effective in preventing diabetes in older individuals; this finding was largely explained by greater weight loss and physical activity. The limited effectiveness of metformin in older persons may reflect age-related differences in insulin action and secretion. A lifestyle modification program can be recommended for older individuals at high risk for type 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=33750918489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750918489&partnerID=8YFLogxK

U2 - 10.1093/gerona/61.10.1075

DO - 10.1093/gerona/61.10.1075

M3 - Article

VL - 61

SP - 1075

EP - 1081

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 10

ER -